View Older Stories View More Recent Stories

Nov 30, 2022 07:00AM PureTech Announces New Therapeutic Candidate, LYT-310, an Oral Form of Cannabidiol (CBD) Leveraging PureTech’s Glyph™ Platform
Nov 17, 2022 07:00AM PureTech to Present at Two Upcoming Investor Conferences
Nov 9, 2022 07:17AM PureTech to Present at the Jefferies London Healthcare Conference
Nov 1, 2022 07:00AM PureTech to Present at the Credit Suisse 31st Annual Healthcare Conference
Sep 8, 2022 07:00AM PureTech to Present at the Morgan Stanley Global Healthcare Conference
Sep 6, 2022 07:00AM PureTech Presents Data for LYT-100 (Deupirfenidone) Supporting Design of Dose-Ranging Trial in Idiopathic Pulmonary Fibrosis (IPF) at European Respiratory Society International Congress 2022
Aug 25, 2022 02:07AM PureTech Health plc – Half-Year Report
Aug 24, 2022 11:05AM PureTech Founded Entity Sonde Health Announces Multi-Year Partnership with Koye Pharmaceuticals
Aug 4, 2022 02:00AM PureTech Health: Notice of Half-Yearly Results
Aug 1, 2022 07:05AM PureTech Health's (PRTC) Akili Announces Phase 3 Study of Digital Treatment in Children with ADHD Begun by Shionogi in Japan
Aug 1, 2022 07:05AM PureTech Founded Entity Akili Announces Phase 3 Study of Digital Treatment in Children with ADHD Begun by Shionogi in Japan
Jul 14, 2022 07:06AM PureTech Health's (PRTC) Akili Announces Publication Demonstrating Improved Executive Function in Patients with Systemic Lupus Erythematosus Following Use of AKL-T01 Product Candidate
Jul 14, 2022 07:05AM PureTech Founded Entity Akili Announces the Journal Lupus Publishes Investigator-Initiated Study Results Demonstrating Improved Executive Function in Patients with Systemic Lupus Erythematosus Followi
Jul 11, 2022 07:05AM PureTech Founded Entity Akili Announces Public Company Board of Director Nominees
Jun 30, 2022 07:00AM PureTech Initiates Late-Stage Clinical Study of Wholly-Owned Candidate LYT-100 (Deupirfenidone) in IPF and Advances LYT-200 (Anti-Galectin-9 mAb)
Jun 28, 2022 07:35AM PureTech Founded Entity Vedanta Biosciences Unveils State-of-the-Art Manufacturing Facility to Provide Clinical and Commercial Supply of Oral Therapies Based on Defined Bacterial Consortia
Jun 15, 2022 01:40PM Results of Annual General Meeting
Jun 14, 2022 06:08AM PureTech Health Plc (PRTC) Announces Phase 2 Results of LYT-100-COV in Post-Acute 'Long' COVID
Jun 14, 2022 02:01AM PureTech Meets Milestone of Achieving Oral Bioavailability of Allopregnanolone in Healthy Adults Dosed with LYT-300
Jun 14, 2022 02:00AM PureTech Reports Results from Phase 2 Study of LYT-100-COV in Post-Acute “Long” COVID with Respiratory Complications
Jun 6, 2022 07:05AM PureTech Health Plc (PRTC) Announces Akili Appoints Matt Franklin as President and COO
Jun 6, 2022 07:05AM PureTech Founded Entity Akili Announces Veteran Life Sciences Executive Matt Franklin in Newly Created Role of President and Chief Operating Officer
Jun 1, 2022 07:00AM PureTech to Present at the Jefferies Healthcare Conference
May 26, 2022 07:05AM PureTech Health's (PRTC) Akili Integrates Prescription Video Game Treatment with the Virtual World Through Partnership with Roblox
May 26, 2022 07:05AM PureTech Founded Entity Akili Integrates First-of-its-Kind Prescription Video Game Treatment with the Virtual World Through Partnership with Roblox
May 24, 2022 05:50AM PureTech's (PRTC) Vedanta Biosciences Presented Data from Multiple Studies
May 24, 2022 03:05AM PureTech Founded Entity Vedanta Biosciences Presents Data from Multiple Studies at Digestive Disease Week 2022 Annual Meeting
May 17, 2022 07:00AM PureTech to Present at the UBS Global Healthcare Conference
May 16, 2022 09:30AM PureTech (PRTC) Presents Additional Phase 1 Data for LYT-100
May 16, 2022 09:30AM PureTech Presents Additional Phase 1 Data for LYT-100 at American Thoracic Society 2022
May 9, 2022 02:00AM PureTech Announces Share Buyback Program Update
May 5, 2022 05:46AM PureTech Health Plc (PRTC) Announces $50M Share Buyback
May 5, 2022 02:00AM PureTech Announces Share Buyback Program of up to $50 Million
May 4, 2022 06:35AM PureTech Founded Entity Gelesis Announces Clinical Data Demonstrating Weight Loss with GS200 in Adults with Prediabetes and Type 2 Diabetes Presented at the European Congress on Obesity 2022
Apr 29, 2022 06:05AM PureTech Founded Entity Gelesis Announces its Proprietary Superabsorbent Hydrogel Induced Beneficial Changes to the Gut Microbiota and Expanded Akkermansia, a Bacterial Species Associated with Gut Hea
Apr 26, 2022 02:00AM PureTech Announces Annual Results for Year Ended December 31, 2021
Apr 13, 2022 11:58AM PureTech's (PRTC) Founded Vedanta Biosciences Publishes Phase 1a/1b Results for Lead Program VE303
Apr 13, 2022 11:46AM PureTech Founded Entity Vedanta Biosciences Publishes Phase 1a/1b Results for Lead Program VE303 in Cell Host & Microbe and Highlights Planned Presentations of Phase 2 VE303 Results
Apr 12, 2022 07:06AM PureTech Health-Founded (PRTC) Akili Interactive Reports Publication of Data Demonstrating its Digital Therapeutic AKL-T03 Improves Cognitive Impairments in Adults w/ Major Depressive Disorder When Co
Apr 12, 2022 07:05AM PureTech Founded Entity Akili Announces American Journal of Psychiatry Publication of Data Demonstrating its Digital Therapeutic AKL-T03 Improves Cognitive Impairments in Adults w/ Major Depressive Di
Apr 12, 2022 05:41AM PureTech Health (PRTC) Announces Publication from Collaborators Demonstrating PureTech’s Glyph Platform Enhances Oral Absorption of Buprenorphine
Apr 12, 2022 02:00AM PureTech Announces Publication of Research from Collaborators Demonstrating PureTech’s Glyph™ Platform Enhances Oral Absorption of Buprenorphine (a Clinically-Validated Opioid Replacement Therapy)
Apr 7, 2022 02:00AM PureTech Health: Notice of Results
Mar 24, 2022 03:00AM PureTech Appoints Sharon Barber-Lui to Board of Directors & Audit Committee
Mar 17, 2022 09:06AM PureTech Health's (PRTC) Akili Appoints Jon David as Chief Product Officer
Mar 17, 2022 09:05AM PureTech Founded Entity Akili Appoints Game Industry Veteran Behind Bejeweled, Plants vs. Zombies as Chief Product Officer
Mar 16, 2022 06:36AM PureTech Health's (PRTC) Gelesis Holdings (GLS) Reports Record Preliminary National Launch Results for Plenity
Mar 16, 2022 06:35AM PureTech Founded Entity Gelesis® Releases Preliminary National Launch Results for Plenity®: Record-Breaking Levels of Prescriptions and Online Traffic
Mar 8, 2022 07:05AM PureTech Founded Entity Akili Named to Fast Company’s Annual List of the World’s 50 Most Innovative Companies for 2022
Feb 17, 2022 07:05AM PureTech Founded Entity Akili Announces PLOS ONE Publication of Clinical Study Results and EEG Data Showing Akili Digital Therapeutic EndeavorRx® Activates Systems in Brain Key to Attentional Functio
View More Recent Stories View Older Stories